Linköping University Hospital is a university hospital in Linköping, Sweden, operated by Östergötland County. Its scientific activities are integrated into the medical faculty of Linköping University. The hospital has all specializations except organ transplantation.

During the past decade, Linkoping University Hospital conducted 95 clinical trials. In the 10-year time frame, 95 clinical trials started and 13 clinical trials were completed, i.e. on average, 13.7% percent of trials that started reached the finish line to date. In the past 5 years, 29 clinical trials started and 5 clinical trials were completed. i.e. 17.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Linkoping University Hospital" #1 sponsor was "University Hospital, Linkoeping" with 28 trials, followed by "Karolinska Institutet" with 21 trials sponsored, "Linkoeping University" with 12 trials sponsored, "Uppsala University" with 11 trials sponsored and "European Organisation for Research and Treatment of Cancer - EORTC" with 11 trials sponsored. Other sponsors include 100 different institutions and companies that sponsored additional 89 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Linkoping University Hospital" #1 collaborator was "University Hospital, Linkoeping" with 23 trials as a collaborator, "Sahlgrenska University Hospital, Sweden" with 16 trials as a collaborator, "Karolinska University Hospital" with 14 trials as a collaborator, "Skane University Hospital" with 12 trials as a collaborator and "Uppsala University Hospital" with 12 trials as a collaborator. Other collaborators include 337 different institutions and companies that were collaborators in the rest 221 trials.

According to Clinical.Site data, the most researched conditions in "Linkoping University Hospital" are "Breast Cancer" (6 trials), "Heart Failure" (5 trials), "Myocardial Infarction" (5 trials), "Acute Coronary Syndrome" (4 trials) and "Colorectal Cancer" (4 trials). Many other conditions were trialed in "Linkoping University Hospital" in a lesser frequency.

Most popular intervention types in "Linkoping University Hospital" are "Drug" (80 trials), "Procedure" (35 trials), "Other" (24 trials), "Device" (22 trials) and "Biological" (15 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (18 trials), "radiation therapy" (5 trials), "Guselkumab" (4 trials), "Golimumab" (3 trials) and "Rituximab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Linkoping University Hospital" are 155 trials for "All" genders, 23 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are 63 active trials in "Linkoping University Hospital". 1 are not yet recruiting, 41 are recruiting, 20 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 90 completed trials in Linkoping University Hospital, undefined suspended trials, and 14 terminated clinical trials to date.

Out of the total trials that were conducted in Linkoping University Hospital, 4 "Phase 1" clinical trials were conducted, 30 "Phase 2" clinical trials and 49 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 14 trials, and there were also 68 trials that are defined as “Not Applicable".